CAMBRIDGE, MASSACHUSETTS – October 29, 2008. IntelligentMDx announced today that Drs. Richard S. Buller and Gregory A. Storch from the Department of Pediatrics at Washington School of Medicine in St. Louis, Missouri would be presenting a poster entitled “Evaluation of Intelligent Medical Devices Inc. Real-Time PCR TaqMan – Reagents for the Detection and Quantitation of Human BK Polyoma Virus in Clinical Specimens” at the 14th Annual Association for Molecular Pathology Meeting in Grapevine, Texas.
IntelligentMD™ develops and manufactures tests, under regulatory compliance, for a broad range of molecular based systems for use in clinical diagnostics, drug development and applied science applications. Our mission is to rapidly translate the needs of the clinician, patient and partners into very specific, highly sensitive, robust clinically impactful tests, thus enabling caregivers worldwide to provide care with certainty.
IntelligentMDx’s competitive advantage incorporates intelligent software with assay development and manufacturing expertise within a Quality System compliant with both ISO and FDA current regulations. Our uniquely integrated modular test development process provides clinically impactful and novel molecular testing solutions. The company is working to use its proprietary “symptom-based diagnostics” approach for disease detection. Our goal is to provide the end users with “smart” tests that detect several related diseases at once – more quickly and more economically than current standard individual tests. The quality and breadth of our product candidate pipeline, platform-agnostic approach, scientific team and strategic collaborations and partnerships is enabling us to become a fully integrated diagnostics company.
CONTACT: For more information on IntelligentMDx, visit www.IntelligentMDx.com or email info@intelligentMDx.com.